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Inﬂammatory host response proﬁleSeveral early pandemic H1N1 inﬂuenza isolates cause severe disease in different animals models, while most
strains result in mild clinical signs similar to seasonal inﬂuenza. In this study, the pathogenesis of the virulent
Mexican isolate A/Mexico/InDRE4487/2009 and a mild Canadian isolate A/Canada-AB/RV1532/2009 was
compared in ferrets. These viruses differed at nine residues, none of which has been previously identiﬁed
as virulence factor. The Mexican isolate caused more severe disease and higher mortality, and reached higher
peak nasal wash titers. Both viruses grew similarly in the respiratory tract, but only the virulent virus was
detected in the gut after day 3. During the acute phase, both strains caused similar lung pathology, however
the Mexican isolate induced severe inﬂammation even after virus clearance. This virus was also associated
with a rapid and sustained induction of inﬂammatory cytokines, indicating that early dysregulation of the
host response contributes importantly to the disease outcome.
© 2011 Elsevier Inc. All rights reserved.Introduction
In April 2009, a novel reassortant H1N1 inﬂuenza virus emerged,
combining segments of human, avian, and Eurasian and North American
porcine origin (Smith et al., 2009). In contrast to contemporary seasonal
inﬂuenza strains, most pandemic H1N1 2009 (pH1N1) viruses express a
truncated PB1-F2 protein, a putative virulence factor, but its reconstitu-
tion did not result in increased virulence (Hai et al., 2010). Furthermore,
the pH1N1 NS1 protein carries amino acid changes abolishing its ability
to block host gene expression and lacks the 11C terminal residues, com-
pared to NS1 proteins originating from seasonal human strains (Hale et
al., 2010a; 2010b). However, restoration of host gene expression inhibi-
tion and expression of the full length protein did not result in increased
virulence in mice or ferrets (Hale et al., 2010a; 2010b), while introduc-
tion of mutations in the C-terminal part that result in a PDZ domain as
found in NS1 proteins of seasonal viruses increased the virulence in
mice (Ozawa et al., 2011). Similarly, mutation of PB2 residues E627K
and D701N, which contribute importantly to mammalian host adapta-
tion, from the avian consensus originally found in pH1N1 viruses to thedical School, 8 College Road,
u.sg (V. von Messling).
rights reserved.mammalian consensus did not increase replication efﬁciency in mam-
malian cells or virulence (Herfst et al., 2010). More recently, a contribu-
tion to virulence was proposed for the D222G mutation in the
hemagglutinin (HA) protein found in several severe clinical cases, but
further characterization revealed an alteration in receptor binding but
no increase in virulence or transmissibility (Chutinimitkul et al., 2010).
However, despite the absence of most known virulence-enhancing mu-
tations, this virus rapidly spread worldwide, causing the ﬁrst pandemic
of the 21st century (Fraser et al., 2009; Garten et al., 2009).
Even though the disease severity and case fatality rate associated
with pH1N1 has been similar to seasonal inﬂuenza (Khandaker et
al., 2011; Pebody et al., 2010), an increased incidence of pneumonia
and deaths has been observed in young adults (Chowell et al.,
2009). Compared to seasonal H1N1 strains, pH1N1 viruses have a
stronger tropism to the lower respiratory tract and cause more severe
inﬂammatory changes in the lung in different animal models, even
though the clinical disease is similar (Itoh et al., 2009; Maines et al.,
2009). However, certain early isolates cause more severe disease in
ferrets and cynomolgus macaques (Kobinger et al., 2010; Safronetz
et al., 2011), indicating that the few genetic differences between
pH1N1 strains importantly inﬂuence their virulence.
The present study compares the pathogenesis and host responses of
a virulent early Mexican isolate and a mild Canadian isolate in ferrets.
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126 I. Meunier et al. / Virology 422 (2012) 125–131We observed that both viruses caused similar inﬂammation in the lung
at early disease stages and replicated with similar efﬁciency. However,
the more virulent strain was associated with higher peak nasal wash ti-
ters, prolongued presence in the gastro-intestinal tract, sustained in-
ﬂammation after virus clearance and a distinct cytokine proﬁle.
Results
The virulent Mexican and mild Canadian isolates differ by only nine amino
acids
To investigate the heterogeneity in disease severity observed for early
pH1N1 viruses, we chose the Mexican isolate A/Mexico/InDRE4487/
2009 (MX4487) obtained from a patient with severe disease, and
the Canadian isolate A/Canada-AB/RV1532/2009 (RV1532), which
originated from a patient with unremarkable inﬂuenza-like symptoms.
The PB1 and M segments are completely identical for both viruses and
correspond to the pH1N1 consensus, while one conservative amino
acid exchange is found in each of the PA, NP, and NS1 genes (Table 1).
In addition, the PB2, HA, and NA segments differ at two amino acids.
Compared to the pH1N1 consensus, there is one additional amino acid
difference in PA, and two in HA. The amino acid substitution in NS1 is
located in the PKR-binding domain of the protein and varies among
pandemic strains (Pan et al., 2010), while HA serine 203 (mature HA
numbering), located in the Ca1 epitope, is proposed to be under selec-
tive pressure to change to tyrosine (Ding et al., 2010). However, none
of the differing residues have been identiﬁed as virulence markers.
MX4487 causes a more severe disease than RV1532
To assess the virulence of the two strains in ferrets, nine animals
were infected intranasally with 5×105 PFU of either isolate. All ani-
mals rapidly developed a fever that peaked at day 1 post-infection
and elevated body temperatures were observed for the following
3–4 days (Fig. 1a). Regardless of the virus used, an up to 12% weight
loss was observed over the ﬁrst week followed by a gradual recovery
until the end of the study (data not shown). With the exception of
one animal that developed severe disease and had to be sacriﬁced
on day 6, RV1532-infected ferrets experienced mild to moderate con-
gestion, some sneezing, and mild depression during the ﬁrst week
after infection and had completely recovered by day 12 (Fig. 1b). In
contrast, MX4487-infected animals rapidly developed severe signs
of disease including purulent nasal exudate, moderate to severe con-
gestion, irregular and labored breathing, and frequent sneezing andTable 1
Comparison of the amino acid residues differing between A/Mexico/InDRE4487/2009
and A/Canada-AB/RV1532/2009 with the pH1N1 consensus.
Segment Consensus pH1N1 MX4487 RV1532
Seg. 1 (PB2)
Pos 30 Ile Ile Val
Pos 82 Asn Ser Asn
Seg. 3 (PA)
Pos 224 Pro Ser Ser
Pos 275 Leu Ile Leu
Seg. 4 (HA)a
Pos 83 Pro Ser Ser
Pos 87 Asn Asn Lys
Pos 203 Ser Ser Thr
Pos 321 Ile Val Val
Seg. 5 (NP)
Pos 100 Val Val Ile
Seg. 6 (NA)
Pos 106 Val Val Ile
Pos 248 Asp Asn Asp
Seg. 8 (NS1)
Pos 123 Ile Ile Val
a Mature H1N1 HA numbering.coughing, as well as severe depression (Fig. 1b). One of the animals
was euthanized on day 6 after being found unresponsive (Fig. 1c),
and three animals reached experimental endpoints and were sacri-
ﬁced on day 9, resulting in 44% mortality. Even though larger group
sizes would be required to determine if this difference in mortality
is statistically signiﬁcant, there was a clear difference in the disease
severity observed.
MX4487 and RV1532 replicate with similar efﬁciency in the respiratory
tract
Wenext compared the replication of the twoviruses. For both viruses,
peak nasal wash titers were observed at day 1 post-infection, but
MX4487-infected animals reached around tenfold higher levels
(Pb0.0001). Titers declined gradually until the virus was cleared on day
7 (Fig. 2a), with genome copies being detectable in both cases until the
end of the study on day 12 (data not shown). To evaluate the replication
of the viruses in different tissues, two animals of each group were sacri-
ﬁced at days 3, 6, and 9post-infection, and trachea, lungs, and small intes-
tine were harvested. Both replicated efﬁciently in the upper and lower%
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Fig. 1. Pathogenesis and virulence of the different isolates. Body temperature (a), clinical
scores (b), and survival curves (c) at various times after infection. Groups of nine ferrets
were infected with 5×105 PFU of the different isolates and the infection was monitored
daily. Days post-infection are indicated on the X axis, clinical score, body temperature,
and percent survival are plotted on the respective Y axes. The clinical score represents
the sum of activity, and upper and lower respiratory sign scores, each graded on a 0–1–
2–3 scale, as outlined in the material and methods. Error bars represent the standard de-
viation (SD).
127I. Meunier et al. / Virology 422 (2012) 125–131respiratory tract, reaching comparable titers at day 3 post-infection
(Fig. 2b and c). However, while RV1532 sustained replication through
day 6, MX4487 was rapidly cleared. Quantiﬁcation of viral genome copy
numbers in rectal swabs revealed that both viruses were detectable at
similar levels on day 3 (Fig. 2d), but only MX4487 was found at later
time points (Pb0.05 on day 6) and could be isolated from the small intes-
tine on days 3 and 6 (Fig. 2e).
MX4487 causes more sustained and widespread lung damage
As reported previously, pH1N1 viruses cause more severe lung pa-
thology than seasonal strains (Itoh et al., 2009). Both isolates ana-
lyzed here caused similar histopathological changes at early disease
stages, but the damage was more widespread in the case of
MX4487. Three days after infection, lesions were characterized by se-
vere alveolitis and bronchiolitis with necrosis and loss of bronchiolar
epithelium and accumulation of neutrophils and necrotic debris with-
in bronchiolar lumina, as well as alveolar and perivascular edema
(Fig. 3a and b, stars). Alveolar walls were expanded by inﬂammatory
cells, edema and hyperplastic pneumocytes, and frequent perivascu-
lar cufﬁng was observed (Fig. 3a and b, arrows). At day 6, there was
a widespread of acute and severe alveolitis in MX4487 sections char-
acterized by alveoli ﬁlled with edema, ﬁbrin, hemorrhage and exten-
sive inﬁltrates consisting of neutrophils and macrophages (Fig. 3c,
stars) as well as thickening of alveolar walls by inﬂammatory inﬁl-
trates. Many bronchioles were destroyed with evidence of extensive
necrosis and neutrophil inﬁltration leaving only a remnant of smooth
muscle tissue. Large consolidated areas with complete loss of alveolar
spaces and severely damaged bronchioles containing central areas of
ﬁbroblast proliferation were observed (data not shown). In contrast,
RV1532 lung sections were characterized by hyperplasia of the air-
way epithelium,lymphocytoplasmatic cufﬁng of small airways and
vessels and multifocal areas of pneumocyte hyperplasia (Fig. 3d). At
day 9, lung tissue from MX4487-infected animals still contained
large areas of consolidation with perivascular cufﬁng (Fig. 3e, stars).
Some of the more severely affected bronchioles had been destroyed,a
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(e), and. Nasal washes and rectal swabs were collected at days 1, 3, 5/6, 7, 9 and 12 post-in
expressed as TCID50/ml. At days 3, 6, and 9 after infection, two ferrets of each group was sacr
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SD. Statistical signiﬁcance was determined using the Mann Whitney test, and two stars indwhile others were undergoing repair as indicated by regenerating ep-
ithelium (Fig. 3e, arrow), and had evidence of bronchiolitis obliterans.
In contrast, only focal mild consolidation was seen in RV1532 sections
with multifocal areas of bronchiolar epithelial hyperplasia (Fig. 3f,
arrow), and lymphocytoplasmacytic cufﬁng around airways and arte-
rioles. For both viruses, there was a widespread infection of bronchial
epithelia on day 3, but viral antigen was only detected occasionally on
day 6 in MX4487 tissues, while infection levels were moderately
higher in RV1532 sections with approximately twice the number of
infected cells (Fig. 4), consistent with the higher viral titers observed
(Fig. 2c). All sections were negative on day 9 (data not shown). Colo-
nization of the respiratory tract by bacteria as another possible con-
tributor of inﬂamation and damages was not detected at any
timepoint.
MX4487 induces a strong inﬂammatory response
To evaluate the contribution of the local innate host response to
the differences in pathogenesis, we compared the nasal wash cyto-
kine proﬁles including IL-6, IL-8, TNF-α, IFN-α, and IFN-γ induced
by the two pH1N1 strains with samples of the highly virulent H1N1
strain A/BM/1/1918 (1918) collected during a previous experiment
(Pillet et al., 2011). Toward this, cytokine mRNA present in the
nasal washes at days 1 and 3 post-infection were quantiﬁed by
semi-quantitative real-time RT-PCR. On day 1, MX4487 induced sig-
niﬁcantly higher levels of the pro-inﬂammatory cytokines IL-6, IL-8,
and TNF-α, than RV1532 or 1918 (Pb0.001, Pb0.05, and Pb0.001, re-
spectively) (Fig. 5a–c). A similar trend was observed at day 3 post-
infection, although the differences were not statistically signiﬁcant.
Consistent with the previously reported initial type I IFN antagonizing
capacity of the 1918 virus in macaques (Kobasa et al., 2007), this virus
was also the weakest inducer of IFN-α on day 1 with levels being
more than tenfold lower than in MX4487-infected animals (Pb0.05)
(Fig. 5d). However, MX4487 and 1918 both induced tenfold more
IFN-α than RV1532 (Pb0.05) on day 3, again reproducing the pattern
observed in macaques (Kobasa et al., 2007). Both pH1N1 strains100
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Fig. 3.Histopathological examination of lung tissue. H&E stained slides fromanimals infectedwithMX4487 orRV1532, respectively, and sacriﬁced at days 3 (a, b), 6 (c, d), and 9 (e, f)were
examined for pathological changes. (a and b)At 3 dpi there is expansion of alveolarwalls due to inﬂammatory inﬁltrates and hyperplastic pneumocytes. Alveolar spaces contain edema (*)
and lymphohistiocytic perivascular cufﬁng is observed (arrow). (c) At 6 dpi there is alveolitiswith edema,ﬁbrin, hemorrhage and inﬂammatory inﬁltrates (*). (d) At 6 dpi themost prom-
inent lesion is multifocal bronchiolitis. (e) Large areas of the lung remain consolidated at 9 dpi. Note perivascular cufﬁng (*). A bronchiole undergoes remodeling and repair evidenced
by luminal ﬁbroblastic proliferation and regenerating epithelium (arrow). (f) At 9 dpi there is bronchiolar epithelial hyperplasia (arrow) and peribronchiolar lymphoplasmacytic cufﬁng
(arrowhead). Bar=50 μm.
128 I. Meunier et al. / Virology 422 (2012) 125–131resulted in rapid upregulation of IFN-γ, with MX4487 reaching ten-
fold higher levels, and expression was sustained through day 3
(Fig. 5e). In contrast, the 1918 virus resulted in IFN-γ downregulation
on day 1 and returned to baseline levels on day 3 (Fig. 5e), indicating
that there was no local type II IFN induction in nasal wash cells of
these animals.
Discussion
Despite their overall genetic similarity, early pH1N1 strains vary
considerably in their virulence in different animal models (Itoh et
al., 2009; Safronetz et al., 2011). To characterize pathogenesis differ-
ences of mild and severe disease in more detail, we compared the dis-
ease severity, viral load, pathology, and nasal wash cytokine proﬁle of
the highy virulent Mexican strain MX4487 and the mild Canadian
strain RV1532 in ferrets. MX4487 and RV1532 differ at HA residues
N87K and S203T, and both strains have an exchange at positions 83
(P83S) and 321 (I321V) compared to the pH1N1 consensus sequence.
A comparison of MX4487 with the mild Mexican strain A/Mexico/
4108/2009 and a consensus pH1N1 sequence revealed one additional
difference at residue V427I (Safronetz et al., 2011). However, none of
these changes have been implicated as virulence factors, and all ofthem are found in the respective mild strain. Similarly, of the two
amino acid changes in NA, RV1532 diverges at position V106I from
the overall pH1N1 consensus, and the N248D exchange found in the
virulent strain is not thought to alter the protein structure or function
(Morlighem et al., 2011), indicating that the observed differences in
virulence are not due to altered receptor binding or entry.
While PB1 is completely conserved among all strains, one change
each was found in PB2 and PA. These two exchanges, N82S in PB2 and
L275I in PA, represent amino acids in which MX4487 differs from the
overall pH1N1 consensus, suggesting a contribution of the replication
complex to the observed increase in virulence. MX4487 did indeed
result in tenfold higher peak nasal wash titers on day 1 post-
infection, but the titers at later times and in respiratory tissues were
similar for both strains. In ferrets, the highly pathogenic H1N1 1918
strain also results in hundred- to thousandfold higher nasal wash ti-
ters compared to seasonal H1N1 strains (Pillet et al., 2011; Tumpey
et al., 2007), indicating a correlation between replication efﬁciency
at very early disease stages and virulence for H1N1 and possibly
human inﬂuenza viruses of other subtypes.
Consistent with other pH1N1 studies in ferrets (Maines et al.,
2009), we detected viral RNA in rectal swabs from both groups on
day 3 after infection. However, our comparison of the two closely
Fig. 4. Immunohistochemical detection of infected cells. Lung sections stained with an inﬂuenza A-speciﬁc antiserum from animals infected with MX4487 or RV1532, respectively,
and sacriﬁced at days 3 (a, b) and 6 (c, d). At 3 dpi, lung tissue from ferrets infected with (a) MX4487 and (b) RV1532 shows detection of viral antigen extensively in bronchiolar
epithelium (arrowheads) as well as within alveolar walls (arrows). Bar=100 μm. (c) Lung tissue at 6 dpi from Mx4487-infected ferret shows scattered immunopositive cells
(arrow). Bar=50 μm. (d) Lung tissue at 6 dpi from RV1532-infected ferret shows moderate numbers of immunopositive cells including alveolar macrophages (arrow) as well
as pneumocytes (arrowhead). Bar=50 μm.
129I. Meunier et al. / Virology 422 (2012) 125–131related strains revealed that only RNA of the virulent strain MX4487
was detectable on days 6 and 9, linking sustained viral presence in
the intestinal tract to more severe disease. This is supported by the re-
port of diarrhea in up to 30% of clinical pH1N1 patients (Di
Giambenedetto et al., 2011; McLean et al., 2010), and frequent detec-
tion of viral RNA in stool samples of clinical cases (To et al., 2010). In101
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Data were analyzed by a one-way analysis of variance followed by Tukey's a posteriori testferrets, infection of the gastro-intestinal tract is regularly observed in
the context of H5N1 infections and has been described for other avian
viruses viruses (Kawaoka et al., 1987). It has recently been proposed
that H5N1 viruses or inﬂammatory cytokines produced in the gut
may be transported to the lung via the intestinal lymphatic system,
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130 I. Meunier et al. / Virology 422 (2012) 125–131thereby providing direct access to the pulmonary circulation (Shinya
et al., 2011). It is thus conceivable that a local inﬂammatory response
elicited by prolonged replication of MX4487 in the gastrointestinal
tract contributes to the exacerbated lung inﬂammation observed.
The rapid induction of the pro-inﬂammatory cytokines IL-6 and
TNF-α aswell as IFN-α seen only in MX4487-infected animals supports
the correlation between a dysregulation of the host response at early in-
fection stages and increased mortality associated with more virulent
pH1N1 strains. In contrast, the highly pathogenic H1N1 1918, which
has a similar mortality rate (Memoli et al., 2009; Tumpey et al., 2007),
initially delays the inﬂammatory response with IFN-α starting to be
upregulated only on day 3. This observation reproduces microarray re-
sults obtained from 1918-infected macaques, where the activation of
the innate and inﬂammatory response was also delayed compared to
a seasonal strain (Kobasa et al., 2007). Taken together, our study indi-
cates that excessive inﬂammatory responses, possibly triggered by
rapid replication during the ﬁrst infection stages and exacerbated by
sustained replication in the gut, play an important role in severe
pH1N1 disease, suggesting that appropriately timed immunosuppres-
sive treatment in conjunction with anti-viral therapymay be beneﬁcial.
Materials and methods
Cells and viruses
Virus isolates A/Mexico/InDRE4487/2009 (MX4487) and A/Canada-
AB/RV1532/2009 (RV1532) were obtained by direct passage of a pa-
tient bronchial aspirate specimen on Madin-Darby canine kidney
(MDCK) cells (ATCC CCL-34) in the presence of 1 μg/ml TPCK-trypsin
(Sigma, Oakville, ON) in minimal essential medium (MEM, Invitrogen,
Burlington, ON) supplemented with 0.1% bovine serum albumin and
antibiotics (MEM/BSA). All viruses used for experimentation were
from the second passage in MDCK cells. Viral titers were determined
by plaque assay on MDCK cells and are expressed as plaque-forming
units (PFU).
Animal experiments
All animal experiments were approved by the institutional animal
care and use committee of the National Microbiology Laboratory
(NML) and performed according to the guidelines of the Canadian
Council on Animal Care. Four to six months old female ferrets were
purchased from Marshall Farms (North Rose, NY) and conﬁrmed to
be seronegative for circulating H1N1 and H3N2 inﬂuenza viruses.
Groups of nine ferrets were intranasally infected with 5×105 PFU of
the respective virus, and body temperature and weight were
recorded daily. To capture differences between moderate and severe
disease, a new 0–1–2–3 scoring scale was established, with 0 repre-
senting a physiological state, evaluating the following eight criteria:
(1) nasal exsudate quality: serous/mucous/purulent; (2) nasal exsu-
date quantity: little (wet nose)/larger amount (runny nose)/copious
amounts (nose running continuously); (3) congestion: breathing
sounds congested/occasional mouth breathing/continuous mouth
breathing; (4) sneezing: rarely/occasionally/frequently; (5) cough-
ing: rarely/occasionally/frequently; (6) respiratory rate: 30–40/min/
40–50/min/>50/min; (7) dyspnea: occasional wheezing/continuous
wheezing/labored breezing; (8) activity: calm/depressed/inactive.
On days 1, 3, 5, 7, 9 and 12 after infection, animals were anesthe-
tized using isoﬂuran and nasal washes and rectal swabs were collect-
ed. Toward this, 500 μl of PBS was instillated in one nostril and the
expectorate was collected in a 50 ml tube. The procedure was repeat-
ed until a minimal volume of 400 μl was harvested. Rectal swabs were
collected into 1 ml of MEM/BSA. On day 3, 6, and 9 post-infection, two
animals were sacriﬁced and tissues were harvested for titration and
histopathological examination. Tissue samples were placed into RNA-
later (Qiagen) for RNA preservation and subsequent RNA extraction(Qiagen RNeasy), and additional samples of fresh tissue were imme-
diately frozen for viral isolation. The remainder of the tissue was
ﬁxed in 10% phosphate-buffered formalin.
Virus titration and viral RNA quantiﬁcation
Tissues were homogenized in MEM/BSA using a bead mill homoge-
nizer (Tissue Lyser, Qiagen). Cell debris was pelleted by centrifugation
and supernatant was titrated on MDCK cells using the limited dilution
method. At 72–96 h post-infection the plates were scored for cytopathic
effect and titers were expressed as 50% tissue culture infectious doses
(TCID50) per g tissue or perml rectal swab suspension or nasalwashﬂuid.
RNAlater-preserved tissueswere homogenized using a beadmill ho-
mogenizer, and total RNA was extracted using the RNeasy Mini Kit
(QIAGEN). For RNA isolation from nasal washes and rectal swabs the
QIAampViral RNAMini Kit (QIAGEN)was used. Viral RNAwas detected
by quantitative real-time RT-PCR using the LightCycler 480 RNAMaster
Hydrolysis Probes (Roche) assay targeting nucleotides 714–815 of the
HA gene as described previously (Kobinger et al., 2010).
Histology
Tissue sampleswere ﬁxed in 10% neutral phosphate buffered forma-
lin (NBF), embedded in parafﬁn, cut into 5-μm-thick sections, and
stained with hematoxylin and eosin (H&E) for histopathological exam-
ination. For immunohistochemistry, 5 μm sections were cut, air-dried
overnight and placed into a 60 °C oven for 1 h. The deparafﬁnized and
rehydrated sectionswere quenched for 10 min in aqueous 3% hydrogen
peroxide, rinsed in MilliQ water and placed into Tris-buffered saline
plus Tween (TBST) for 5 min. Epitopes were retrieved using proteinase
K (Dako CA, USA) for 15 min. After 2 TBST rinses, the slides were incu-
bated with a H1N1 polyclonal goat antibody (AbD Serotec, OBT1551)
at a dilution of 1:1200 for 1 h, followed by a Goat HRP-Polymer kit
(horse radish peroxidase labeled; BioCare Medical, CA) and a TBST
rinse. Diaminobenzidine (DAB) was used as the substrate chromogen
and the slides were counterstained with Gill's hematoxylin.
Cytokine mRNA quantiﬁcation by real time RT-PCR
Cytokine and GAPDH mRNAs were quantiﬁed by semi-
quantitative real-time RT-PCR using the Quantitect SYBR Green RT
PCR kit (Qiagen, Mississauga, ON) as previously described (Svitek et
al., 2008). Brieﬂy, 10 ng of RNA isolated from cells present in nasal
wash ﬂuids was used in each reaction. Samples originating from ani-
mals infected with the highly pathogenic H1N1 strain BM/1/1918
(Pillet et al., 2011) were also included in the study. Each sample
was analyzed in duplicate and repeated twice or more if the variation
was more than 10%. The fold change ratios between experimental and
control samples for each gene were calculated and normalized
against GAPDH using the ΔΔCt method (Schmittgen et al., 2000).
Statistical analysis
The statistical analyses were performed using GraphPad Prism
5.0a. Data were analyzed by MannWhitney test to identify signiﬁcant
differences in virus titers between the two isolates or with a one-way
analysis of variance followed by Tukey's a posteriori test for compar-
ison between the two isolates and the A/BM/1/1918.
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